interindividu
variabl
suscept
infect
transmiss
diseas
progress
respons
antivir
therapi
attribut
host
determin
variabl
multipl
gene
although
peopl
expos
viru
go
develop
fullblown
diseas
variabl
interv
proport
label
longterm
nonprogressor
expos
uninfect
possess
natur
resist
infect
better
understand
genet
immunolog
basi
natur
resist
infect
would
bear
import
implic
design
therapeut
vaccin
design
genet
variant
could
influenc
suscept
limit
aid
vari
differ
popul
among
individu
metaanalys
larg
cohort
studi
identifi
numer
aid
restrict
gene
regul
hiv
cell
entri
particularli
chemokin
coreceptor
ligand
acquir
innat
immun
major
histocompat
complex
killer
cell
immunoglobulinlik
receptor
cytokin
other
tripartit
interact
motif
apolipoprotein
b
mrnaedit
enzym
catalyt
polypeptidelik
influenc
outcom
hiv
infect
studi
carri
indian
popul
regard
genet
polymorph
chemokin
receptor
shown
protect
variant
rare
ii
carri
associ
increas
likelihood
infect
develop
aid
iii
indian
popul
gener
low
copi
number
data
implic
develop
screen
test
could
identifi
peopl
higher
lower
risk
infect
rate
diseas
progress
predict
vaccin
respons
clinic
trial
understand
pathogen
mechan
immunodefici
viru
siv
subsaharan
africa
transfer
nonhuman
primat
human
zoonosi
initi
transfer
viru
underw
mysteri
chang
sudden
mutat
evolv
began
spread
among
human
across
globe
ultim
becam
true
epidem
hand
rel
less
transmitt
larg
confin
west
africa
believ
strain
may
origin
sooti
mangabey
cercocebu
ati
old
world
monkey
resid
predominantli
guineabissau
gabon
cameroon
http
enwikipediaorg
wikiaidsorigin
sinc
discoveri
viru
earli
import
mileston
understand
patholog
structur
biolog
clinic
immunolog
aspect
infect
achiev
current
focu
defin
genet
immunolog
correl
hostpathogen
interact
view
develop
possibl
biomark
infect
transmiss
diseas
progress
furthermor
despit
impress
develop
antiretrovir
therapi
control
diseas
univers
antihiv
vaccin
still
elud
research
tabl
summar
import
mileston
achiev
sinc
first
instanc
aid
document
took
four
decad
develop
vaccin
polio
chicken
pox
similarli
may
take
still
year
develop
success
vaccin
lack
suitabl
anim
model
system
inher
hypervari
viru
extraordinari
abil
adapt
evolv
host
major
hurdl
respons
delay
develop
vaccin
hiv
tabl
viru
devis
mechan
escap
immun
recognit
surveil
extens
glycosyl
surfac
mask
exampl
envelop
glycoprotein
possess
immunogen
epitop
expos
viru
surfac
therefor
avail
effector
immun
respons
likewis
site
recess
caviti
viru
therefor
inaccess
antibodi
importantli
viru
infect
result
downregul
human
leukocyt
antigen
hla
class
express
effect
perturb
antigen
present
likewis
antibodi
site
report
hinder
antigen
present
suppress
tcell
respons
cell
declin
number
respons
compromis
patient
although
antigen
stimul
induc
chemokin
secret
suppress
hiv
infect
vitro
cell
form
virolog
synaps
noninfect
cell
effici
transfer
virion
cell
cell
viral
particip
format
virolog
synaps
plausibl
lead
dysregul
tcell
activ
analog
immunolog
synaps
normal
result
regul
tcell
activ
host
genet
factor
import
determin
influenc
suscept
viru
infect
subsequ
progress
aid
genet
contribut
larg
known
studi
natur
resist
individu
exampl
longterm
nonprogressor
ltnp
expos
uninfect
eu
person
set
gene
known
govern
viru
entri
andor
develop
effect
innat
adapt
immun
respons
viru
articl
review
import
host
genet
determin
associ
resistancesuscept
infect
slowfast
diseas
progress
respons
therapi
host
genet
individu
variabl
respons
hivaid
numer
studi
shown
extens
interindividu
variabl
exist
respons
hiv
infect
includ
suscept
viru
transmiss
cours
diseas
progress
phenotyp
rang
undetect
asymptomat
state
fatal
aid
individu
equal
suscept
infect
differ
viral
set
point
rate
declin
cell
level
viremia
emerg
ctl
escap
mutant
develop
opportunist
infect
result
vari
incub
period
aid
viru
major
individu
infect
progress
aid
untreat
call
progressor
howev
turn
avirem
antiretrovir
therapi
figur
importantli
infect
individu
develop
aid
year
remain
natur
avirem
refer
ltnp
group
natur
resist
peopl
repres
spontan
control
includ
eu
partner
commerci
sex
worker
well
discord
coupl
spontan
control
possess
level
natur
resist
hiv
combat
infect
initi
viral
exposur
limit
diseas
progress
develop
resist
viru
acquisit
one
current
defin
goal
first
gener
vaccin
therefor
underli
mechan
protect
peopl
hiv
infect
could
hold
key
develop
anticip
vaccin
viru
elit
avirem
control
often
refer
repres
total
infect
individu
maintain
viremia
almost
undetect
level
copi
viral
rna
per
millilit
intermedi
virem
control
manag
maintain
viremia
rna
copi
per
millilit
despit
treatment
figur
allow
consecut
episod
viral
blip
copi
http
orgaidshivelitecontrollersasp
progressor
hand
permit
viru
propag
rna
copi
per
millilit
antiretrovir
therapi
art
viral
load
suppress
undetect
level
intern
collabor
hiv
control
consortium
recent
establish
purpos
recruit
elit
control
differ
ethnic
group
effort
alreadi
led
collect
elit
control
check
wholegenom
scan
immun
respons
hiv
possibl
genet
mechan
may
respons
spontan
control
viru
http
orgaidshivelitecontrollersasp
http
wwwiasusa
org
prime
focu
consortium
understand
host
viral
immunolog
paramet
associ
effect
contain
hiv
infect
recent
studi
shown
specif
immunolog
genet
featur
associ
predominantli
elit
control
could
correl
abil
resist
viru
exampl
person
overrepresent
protect
hlab
b
allel
high
ratio
function
cell
high
gener
activ
level
high
proport
polyfunct
helper
ctl
respons
preferenti
target
gag
env
high
hivspecif
antibodi
level
howev
elit
control
possess
resist
factor
indic
involv
addit
hitherto
undetect
restrict
factor
exampl
brass
et
al
report
hiv
use
least
hostderiv
hiv
depend
factor
gain
entri
target
cell
complet
life
cycl
henc
multipl
genet
factor
expect
involv
diseas
pathogenesi
progress
follow
hiv
infect
studi
carri
obrien
colleagu
use
five
differ
cohort
multicent
hemophilia
cohort
studi
aid
link
intraven
experi
hemophilia
growth
develop
studi
multicent
aid
cohort
studi
san
francisco
citi
cohort
shown
exist
number
aid
restrict
gene
could
determin
genet
propens
individu
popul
help
predict
surviv
kinet
follow
hiv
infect
structur
genom
approach
aim
defin
chromosom
local
host
human
genet
variant
regul
suscept
hiv
infect
rate
declin
viral
load
diseas
progress
respons
therapi
shown
interest
result
set
gene
regul
express
chemokin
cytokin
coreceptor
immun
respons
follow
infect
defin
genet
loci
locat
variabl
chromosom
figur
consortium
approach
metaanalys
shown
fraction
observ
phenotyp
differ
explain
variabl
loci
genet
associ
establish
hivaid
conclus
involv
hla
polymorph
loci
associ
gene
includ
short
arm
chromosom
ii
chemokin
receptor
act
hiv
entri
coreceptor
chemokin
ligand
like
iii
antivir
restrict
factor
tripartit
interact
motif
chromosom
iv
apolipoprotein
b
mrnaedit
enzym
catalyt
polypeptidelik
chromosom
v
dendrit
cellspecif
intracellular
adhes
nonintegrin
dcsign
chromosom
vi
chromosom
vii
interferon
regulatori
factor
viii
famili
g
glycosylphosphatidylinositol
gpi
anchor
protein
other
two
genet
region
name
region
region
establish
genomewid
associ
studi
varieti
popul
group
lack
suitabl
anim
model
system
hypervari
viru
particularli
extens
mutat
viral
protein
env
other
extens
glycosyl
surfac
mask
viral
protein
eg
inaccess
antibodi
epitop
eg
site
recess
caviti
reduc
antigen
present
downregul
human
leukocyt
antigen
class
develop
antibodi
site
declin
tcell
number
dysfunct
inabl
induc
broadli
neutral
antibodi
viru
rapid
emerg
ctl
escap
mutant
populationspecif
variabl
host
genet
immunolog
respons
factor
synergist
opportunist
infect
complic
thereof
figur
spontan
control
vs
diseas
progressor
follow
infect
former
includ
expos
uninfect
eu
like
discord
coupl
commerci
sex
worker
longterm
nonprogressor
ltnp
latter
compos
rapid
slow
progressor
determin
rate
diseas
progress
art
antiretrovir
therapi
chemokin
lowmolecularweight
potent
chemoattract
produc
varieti
cell
type
includ
cell
macrophag
natur
killer
nk
cell
b
cell
fibroblast
mast
cell
involv
cell
traffick
immunomodul
inflamm
immun
respons
certain
instanc
receptor
serv
entri
portal
pathogen
gain
entri
target
cell
establish
infect
exampl
duffi
antigen
receptor
chemokin
darc
use
plasmodium
vivax
preferenti
opt
vast
major
primari
isol
predominantli
tropic
gradual
tend
becom
tropic
late
infect
nonsyncitiuminduc
nsi
strain
requir
chemokin
receptor
gain
entri
target
cell
syncitiuminduc
si
virion
use
enter
ligand
primarili
use
si
virus
therefor
avail
chemokin
receptor
express
cell
surfac
level
ligand
well
cytokin
critic
element
enhancesuppress
hiv
entri
function
genet
polymorph
known
occur
protein
affect
level
express
therefor
might
modul
molecular
interact
known
gene
chemokin
correspond
cc
chemokin
famili
cluster
togeth
chromosom
primari
hiv
coreceptor
locat
chromosom
constitut
extend
haplogroup
valinetoisoleucin
substitut
posit
first
transmembran
region
associ
delay
progress
aid
year
homozyg
individu
carri
wildtyp
allel
protect
allel
occur
popul
frequenc
among
caucasian
chines
north
indian
south
indian
popul
earlier
studi
louisirirotchanakul
et
al
report
homozygos
associ
reduc
risk
acquir
infect
among
hivdiscord
coupl
thailand
howev
indian
popul
polymorph
found
protect
genet
loci
strong
linkag
disequilibrium
combin
analysi
greatli
help
defin
extend
haplotyp
diseas
associ
purpos
multipl
polymorph
variat
describ
gene
natur
knockout
delet
base
ie
introduc
prematur
stop
codon
result
truncat
protein
product
homozyg
state
delet
provid
near
complet
protect
hivinfect
individu
year
delay
diseas
progress
heterozyg
state
found
frequenc
northern
europ
frequenc
decreas
southeast
cline
toward
mediterranean
gradual
disappear
african
asian
popul
extrem
rare
almost
absent
indian
popul
base
uniqu
constel
addit
multisit
polymorph
regulatori
region
number
haplotyp
identifi
illustr
figur
design
base
nucleotid
posit
utr
region
refer
haplogroup
g
hhe
associ
acceler
diseas
progress
caucasian
thai
african
american
latter
hhd
haplotyp
show
posit
associ
fast
progress
aid
similarli
hhc
associ
fast
diseas
progress
african
american
slow
rate
progress
thai
popul
hhg
hhf
associ
slower
progress
among
caucasian
african
american
popul
respect
plausibl
protect
effect
respect
indian
popul
hhe
implic
suscept
infect
develop
aid
whether
haplotyp
also
influenc
diseas
progress
clear
longterm
followup
desir
reach
conclus
cluster
gene
code
pulmonari
activationregul
chemokin
parc
cluster
togeth
within
region
chromosom
potent
chemokin
produc
macrophag
nk
cell
fibroblast
cell
natur
ligand
primari
hiv
coreceptor
genet
polymorph
implic
acquisit
diseas
progress
although
associ
complic
strong
linkag
disequilibrium
monokin
involv
acut
inflammatori
state
recruit
activ
polymorphonuclear
leukocyt
small
induc
cytokin
small
induc
cytokin
ident
protein
level
gene
separ
kb
organ
headtohead
fashion
gene
also
refer
small
induc
cytokin
subfamili
member
parc
contain
three
exon
kb
long
express
high
level
lung
alveolar
macrophag
follicular
dendrit
cell
germin
center
lymph
node
involv
recruit
cell
basophil
asthma
allerg
reaction
upregul
human
cc
chemokin
ligand
like
gene
also
refer
macrophag
inflammatori
small
induc
cytokin
natur
ligand
hiv
coreceptor
potent
suppress
chemokin
physic
block
entri
locat
human
chromosom
figur
share
amino
acid
homolog
although
gene
exist
singl
copi
per
haploid
genom
copi
number
gene
vari
among
differ
individu
popul
group
gene
harbor
sever
singl
nucleotid
polymorph
snp
hotspot
duplic
result
distinct
haplotyp
copi
number
variat
respect
differ
individu
copi
number
highest
african
follow
asian
amerindian
centralsouth
asian
middl
east
individu
european
suggest
potent
ligand
variat
copi
number
thu
express
might
influenc
entri
viru
use
realtim
quantit
polymeras
chain
reaction
townson
et
al
report
occur
two
copi
per
diploid
genom
caucasian
although
individu
could
one
three
four
copi
copi
number
variat
report
associ
suscept
infect
howev
variat
seem
signific
effect
diseas
progress
furthermor
subject
two
less
copi
significantli
higher
risk
acquir
hiv
infect
recent
studi
carri
japanes
popul
shown
averag
copi
number
subject
significantli
lower
healthi
control
ae
vs
ae
p
contrari
studi
north
indian
popul
show
copi
number
variat
effect
acquisit
worth
mention
chimpanze
natur
resist
possess
high
copi
number
base
combin
genotyp
copi
number
delet
mutat
genet
risk
group
defin
could
help
assess
aid
risk
hiv
infect
individu
high
copi
number
delet
point
toward
low
risk
compar
low
copi
number
nondelet
genotyp
furthermor
genotyp
shown
influenc
recoveri
immun
reconstitut
highli
activ
antiretrovir
therapi
recent
studi
report
correl
higher
copi
number
greater
tcell
respons
gag
protein
african
popul
rant
chemokin
rant
also
refer
small
induc
cytokin
mediat
inflamm
also
signific
regul
differenti
develop
natur
ligand
potent
inhibitor
infect
nsi
tropic
report
transvers
g
promot
rant
increas
transcript
polymorph
associ
delay
progress
aid
japanes
popul
anoth
snp
found
regulatori
element
first
intron
rant
associ
downregul
express
implic
acceler
progress
aid
african
american
european
american
recent
studi
report
rant
allel
haplotyp
ii
act
may
risk
factor
transmiss
rant
c
allel
may
confer
risk
diseas
progress
among
north
indian
data
need
replic
larger
cohort
also
popul
group
highli
potent
chemokin
bind
coreceptor
si
strain
induc
intracellular
actin
polymer
lymphocyt
play
import
role
basal
extravaz
lymphocyt
monocyt
therefor
involv
directli
regul
immun
surveil
rather
inflamm
interact
essenti
home
retent
hematopoiet
progenitor
cell
bone
marrow
shown
control
navig
progenitor
cell
bone
marrow
blood
ligand
potent
entri
inhibitor
si
virus
gener
emerg
latestag
hiv
infect
gene
kb
long
locat
human
chromosom
exist
two
isoform
alpha
beta
obtain
consequ
altern
splice
alpha
form
deriv
exon
beta
form
contain
addit
sequenc
exon
common
polymorph
ie
presenc
snp
utr
shown
recess
protect
effect
associ
delay
onset
aid
allel
found
frequenc
caucasian
hispan
african
american
asian
case
north
indian
south
indian
receptor
proinflammatori
cytokin
involv
chemoattract
activ
neutrophil
gene
coloc
region
span
kb
chromosom
figur
similar
sequenc
neutrophil
chemoattract
fmetleuph
studi
indic
dysregul
elev
product
reduc
express
receptor
patient
reduc
activ
upon
infect
crossreceptormedi
intern
major
coreceptor
also
report
observ
suggest
could
affect
aidsrel
condit
gene
consist
sever
polymorph
depend
linkag
disequilibrium
classifi
distinct
haplotyp
two
snp
particular
result
nonsynonym
substitut
ntermin
extracellular
domain
ctermin
intracellular
domain
respect
two
snp
integr
part
haplotyp
ha
recent
genet
studi
french
griv
cohort
compos
rapid
slow
progressor
identifi
strong
associ
haplotyp
ha
protect
rapid
progress
aid
suggest
inhibitori
effect
ha
could
mediat
suppress
express
could
caus
either
direct
involv
palmitoyl
cystein
introduc
cterminu
unknown
signal
regul
express
intracellular
traffick
recent
shown
darc
altern
call
glycoprotein
convent
use
duffybas
blood
group
system
known
receptor
p
vivax
aid
attach
rbc
transinfect
target
cell
duffi
system
locat
chromosom
snp
particular
promot
darc
wide
preval
popul
african
descent
homozyg
genotyp
result
select
loss
darc
express
rbc
genotyp
shown
associ
high
risk
infect
contrari
also
slower
progress
term
death
develop
dementia
suggest
interplay
darc
chemokin
ultim
determin
amount
free
viru
bound
rbc
eventu
transinfect
figur
gene
map
chromosom
polymorph
posit
haplotyp
indic
least
haplotyp
known
arrow
indic
haplotyp
ha
associ
delay
progress
caucasian
dcsign
relat
protein
dcsignr
ctype
lectin
known
bind
multipl
pathogen
mycobacterium
tuberculosi
helicobact
pylori
klebsiella
pneumonia
dengu
viru
ebola
viru
hepat
c
viru
cytomegaloviru
measl
coronaviru
leishmania
pifanoi
shistosoma
mansoni
candida
albican
dcsign
dcsignr
show
homolog
amino
acid
sequenc
level
act
cell
adhes
pathogen
recognit
receptor
involv
innat
adapt
immun
two
gene
appear
origin
common
ancestr
gene
duplic
therefor
locat
close
proxim
headtohead
orient
chromosom
polymorph
dcsign
dcsignr
gene
recent
studi
caucasian
african
popul
sever
novel
snp
identifi
utr
region
investig
report
sever
signific
differ
preval
differ
allel
haplotyp
two
popul
group
gener
african
popul
show
greater
genet
divers
dcsign
popul
dcsign
promot
variant
affect
site
lead
decreas
express
dcsign
particular
allel
associ
suscept
parenter
infect
european
american
associ
report
patient
known
risk
mucos
acquir
infect
total
eight
dcsign
haplotyp
report
tabl
haplotyp
contain
highrisk
snp
associ
parenter
acquir
infect
p
hand
haplotyp
contain
protect
snp
quit
rare
frequenc
make
difficult
test
influenc
actual
risk
follow
infect
although
studi
find
signific
associ
diseas
progress
evid
would
requir
suggest
dcsign
variant
bind
envelop
glycoprotein
virus
effici
might
also
lead
enhanc
viru
infect
addit
gene
act
level
viral
entri
other
critic
involv
hiv
restrict
influenc
ensu
immun
respons
includ
exampl
antivir
gene
famili
viru
restrict
factor
describ
briefli
follow
section
apolipoprotein
b
mrnaedit
enzym
catalyt
polypeptidelik
host
antivir
factor
cytidin
deaminas
induc
gtoa
hypermut
newli
synthes
retrovir
dna
result
instabl
nascent
viral
transcript
lethal
mutat
howev
innat
immun
mechan
counteract
vif
thu
allow
viru
escap
mutat
even
develop
drug
resist
lamivudin
shown
residu
human
african
green
monkey
involv
bind
viral
vif
result
degrad
furthermor
interchang
human
switch
sensit
hiv
vif
siv
vif
function
potent
postentri
restrict
factor
cell
protect
activ
cell
latter
recruit
enzymat
inact
highmolecularmass
ribonucleoprotein
complex
depend
rnase
convers
lowmolecularmass
activ
form
inactiv
form
follow
tcell
activ
correl
permiss
hiv
infect
suggest
creation
hiv
vif
resist
mutat
could
provid
effect
gene
therapi
approach
viru
gene
exist
tandem
array
seven
apobec
gene
pseudogen
chromosom
report
antivir
activ
lost
major
human
popul
exclud
african
two
polymorph
may
import
consequ
suscept
retrovir
infect
antivir
factor
protect
human
primat
broad
rang
retrovirus
speciesspecif
manner
target
capsid
molecul
incom
retroviru
cytosol
disrupt
replic
human
block
ntropic
murin
leukemia
viru
mlv
equin
anemia
viru
dcsign
dendrit
cellspecif
intracellular
adhes
nonintegrin
much
less
effici
restrict
replic
although
escap
mutant
identifi
late
infect
two
snp
report
affect
antivir
activ
restrict
factor
allel
believ
impair
ligas
activ
trim
favor
progress
aid
polymorph
associ
greater
antihiv
activ
earlier
report
frequent
observ
highrisk
seroneg
african
american
compar
hiv
seroposit
patient
recent
van
manen
et
al
analyz
effect
polymorph
clinic
cours
infect
homosexu
men
enrol
amsterdam
cohort
studi
ac
studi
report
acceler
diseas
progress
individu
homozyg
establish
vitro
protect
effect
virus
infect
cell
furthermor
investig
report
allel
along
genotyp
utr
associ
rapid
progress
aid
prevent
vaccin
hivaid
still
elud
research
would
possibl
involv
cellular
humor
immun
respons
viru
expect
first
gener
vaccin
hiv
would
abl
reduc
viremia
copi
rna
per
millilit
andor
prevent
diseas
progress
therebi
result
practic
improv
diseas
outcom
reduc
transmiss
genet
determin
hiv
infect
progress
aid
group
two
broad
categori
first
categori
involv
gene
govern
viral
entri
henc
suscept
includ
chemokin
receptor
ligand
well
other
like
dcsign
darc
second
categori
primarili
influenc
immun
respons
follow
hiv
infect
includ
immun
respons
gene
mhc
region
kir
genet
polymorph
cytokin
genet
studi
aim
identifi
host
factor
associ
natur
resist
retroviru
would
help
develop
screen
test
could
identifi
peopl
greater
lower
predisposit
hiv
infect
could
progress
fastslow
pace
aid
furthermor
genet
test
could
help
clinic
diagnosi
drug
hypersensit
reaction
prior
treatment
could
possibl
translat
avoid
dug
toxic
individu
level
genet
variabl
involv
sever
step
cascad
antivir
immun
surveil
could
help
predict
vaccin
respons
populationspecif
manner
help
understand
diseas
pathogenesi
nevertheless
sever
key
issu
recent
emerg
multidisciplinari
approach
involv
intens
intern
collabor
clear
pathogenesi
involv
complex
counterinteract
respons
mediat
viral
hostderiv
factor
manifest
differ
differ
individu
depend
host
genom
immunom
architectur
number
hostderiv
factor
identifi
casecontrol
studi
multicohort
metaanalys
wholegenom
scan
function
genom
experiment
approach
provid
new
insight
understand
hostpathogen
interact
futur
studi
focus
primarili
mechan
protect
viru
natur
resist
peopl
especi
elit
control
could
unravel
enigmat
approach
could
use
favor
prognosi
vaccin
design
therapi
clinic
practic
